You are on page 1of 1

ATTENTION TO PREVENTION: ESTIMATIVE OF AGREEMENT BETWEEN

CAPILLARY BLOOD GLUCOSE METERS AND INTERSTITIAL GLUCOSE SENSORS


Camila Fernandes Caldato, Neylane Araújo Cordeiro de Santana, Cláudio Eduardo Corrêa Teixeira
Pará State University Center, Medicine, Brazil
AS04. Glucose sensors

BACKGROUNDS AND AIMS RESULTS


Interstitial glucose sensors (IGs) are considered accurate to estimate glycemic Values of glucose obtained with IGs were well-correlated with values of glucose
status, “eliminating” the need for routine fingerstick to measure glycemia. The obtained with CBGm (r = 0.869; R2 = 0.755). However, in the analysis of
rationale for this lies in the fact that linear correlation of measurements agreement between values of glucose obtained with IGs and CBGm, the former
performed with traditional capillary blood glucose meters (CBGm) and IGs are showed values up to ~41 units below or ~74 units above that given by the latter,
assumed as evidence of high agreement between these methods. However, being this disagreement higher in the range of hyperglycemia (> 100 mg/dL)
there is a critical difference between “correlation” and “agreement”: while than in the range of hypoglycemia (< 70 mg/dL).
“correlation” refers to a quantitative relationship between two variables,
“agreement” refers to the concordance between measurements of a unique
variable performed by different methods. Thus, given the relevance of this
issue, we analyzed both “correlation” and “agreement” between CBGm and IGs.

METHODS
Using data from the literature of both capillary blood glucose meters (CBGm)
and interstitial glucose sensors (IGs) obtained of the same individuals (n = 708),
we calculated coefficients of linear correlation and determination and performed
Bland-Altman agreement analysis.

CONCLUSIONS
It is important to discuss how physicians should advise users of IGs about also
performing measurements of glycemia using CBGm, mainly to prevent negative
clinical outcomes due to inconsistencies along diabetes follow-up.

REFERENCES
1. Garber AJ, Handelsman Y, Grunberger G, Einhorn D, Abrahamson MJ,
Barzilay JI, et al. (2020). Consensus Statement by the American Association of
Clinical Endocrinologists and American College of Endocrinology on the
Comprehensive Type 2 Diabetes Management Algorithm - 2020 Executive
Summary. End Pract, 26(1): 107-39.
2. Heinemann L. (2018). Continuous Glucose Monitoring (CGM) or Blood
Glucose Monitoring (BGM): Interactions and Implications. J Diabetes Sci
Technol, 12(4): 873-79. /
3. Bailey T, Bode BW, BW. Christiansen MP, Christiansen MP, Klaff LJ, Alva S.
(2015). The Performance and Usability of a Factory-Calibrated Flash Glucose
Monitoring System. Diab Tech & Therap, 17(11): 787-94.
4. Giavarina D. (2015). Understanding Bland Altman analysis. Biochem Med
(Zagreb), 25(2): 141-51.

You might also like